Literature DB >> 880436

5-HT antagonists inhibit neuroleptic and morphine antagonism of the hyperactivity induced by DA from the nucleus accumbens [proceedings].

B Costall, D H Fortune, R J Naylor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 880436      PMCID: PMC1667440     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  7 in total

1.  Serotoninergic modulation of the dopamine response from the nucleus accumbens.

Authors:  B Costall; R J Naylor; C D Marsden; C J Pycock
Journal:  J Pharm Pharmacol       Date:  1976-06       Impact factor: 3.765

2.  Serotonergic involvement with neuroleptic catalepsy.

Authors:  B Costall; D H Fortune; R J Naylor; C D Mardsen; C Pycock
Journal:  Neuropharmacology       Date:  1975-11       Impact factor: 5.250

3.  Reduced cataleptogenic effects of some neuroleptics in rats with lesioned midbrain raphe and treated with p-chlorophenylalanine.

Authors:  W Kostowski; W Gumulka; A Cxlonkowski
Journal:  Brain Res       Date:  1972-12-24       Impact factor: 3.252

4.  Effect of clozapine on the metabolism of serotonin in rat brain.

Authors:  W Ruch; H Asper; H R Bürki
Journal:  Psychopharmacologia       Date:  1976

5.  Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine.

Authors:  B Costall; R J Naylor
Journal:  Eur J Pharmacol       Date:  1976-01       Impact factor: 4.432

6.  Effects of antagonists upon locomotor stimulation induced by injection of dopamine and Noradrenaline into the nucleus accumbens of nialamide-pretreated rats.

Authors:  A J Pijnenburg; W M Honig; J M Van Rossum
Journal:  Psychopharmacologia       Date:  1975

7.  Characterisation of the mechanisms for hyperactivity induction from the nucleus accumbens by phenylethylamine derivatives.

Authors:  B Costall; R J Naylor; R M Pinder
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.